Raynaud's Disease
Raynaud's Disease ( 33 Questions)
Antihistamines are not commonly used to manage Raynaud's disease. They primarily target histamine receptors and are not effective in dilating blood vessels.
Beta-blockers are not typically prescribed for Raynaud's disease. They may worsen the condition by causing vasoconstriction.
Calcium channel blockers, such as nifedipine or amlodipine, are commonly prescribed to manage Raynaud's disease. These medications help relax and dilate blood vessels, improving blood flow to the extremities and reducing the frequency and severity of Raynaud's episodes.
Oral corticosteroids are not used as a standard treatment for Raynaud's disease. They have anti-inflammatory effects but are not effective in treating the underlying vascular dysfunction of Raynaud's.
A) Antihistamines are not commonly used to manage Raynaud's disease. They primarily target histamine receptors and are not effective in dilating blood vessels.
B) Beta-blockers are not typically prescribed for Raynaud's disease. They may worsen the condition by causing vasoconstriction.
C) Calcium channel blockers, such as nifedipine or amlodipine, are commonly prescribed to manage Raynaud's disease. These medications help relax and dilate blood vessels, improving blood flow to the extremities and reducing the frequency and severity of Raynaud's episodes.
D) Oral corticosteroids are not used as a standard treatment for Raynaud's disease. They have anti-inflammatory effects but are not effective in treating the underlying vascular dysfunction of Raynaud's.